Versant Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $282 | Hold |
13
| – | – | ﹤0.01% | 2580 |
|
|
2025
Q1 | $315 | Hold |
13
| – | – | ﹤0.01% | 2442 |
|
|
2024
Q4 | $271 | Hold |
13
| – | – | ﹤0.01% | 2318 |
|
|
2024
Q3 | $258 | Hold |
13
| – | – | ﹤0.01% | 1944 |
|
|
2024
Q2 | $201 | Hold |
13
| – | – | ﹤0.01% | 1905 |
|
|
2024
Q1 | $207 | Hold |
13
| – | – | ﹤0.01% | 1828 |
|
|
2023
Q4 | $219 | Hold |
13
| – | – | ﹤0.01% | 1856 |
|
|
2023
Q3 | $152 | Hold |
13
| – | – | ﹤0.01% | 1899 |
|
|
2023
Q2 | $175 | Buy |
+13
| New | +$175 | ﹤0.01% | 2001 |
|